肿瘤专科医院药品不良反应报告73例分析 |
| |
引用本文: | 王宇,杨珺,盛明宇,石虹,马金兰.肿瘤专科医院药品不良反应报告73例分析[J].中国药物应用与监测,2009,6(4):236-238. |
| |
作者姓名: | 王宇 杨珺 盛明宇 石虹 马金兰 |
| |
作者单位: | 中国医学科学院肿瘤医院药剂科,北京,100021 |
| |
摘 要: | 目的:对肿瘤患者药品不良反应(ADR)监测的现状进行分析,为今后开展ADR监测工作提供依据。方法:采用回顾性研究方法对我院2008年上报的73例ADR报告进行分类统计,分析ADR发生规律及其特点。结果:73例报表中,用药途径主要为静脉注射,共计63例(86.3%);涉及药物31种,主要为抗肿瘤药物(45.2%);ADR主要表现是全身性损害(27.4%)和呼吸系统损害(21.9%),其次是皮肤及其黏膜的损害。结论:应加强对肿瘤患者ADR的监测工作,以保证用药安全性。
|
关 键 词: | 肿瘤患者 药品不良反应 监测 合理用药 |
Analysis of 73 ADR Cases in Tumor Hospital |
| |
Authors: | WANG Yu YANG Jun SHENG Ming-yu SHI Hong MA Jin-lan |
| |
Institution: | (Depanment of Pharmacy, Tumor Hospital of Chinese Academy of Medical Sciences, Beijing, 100021) |
| |
Abstract: | Objective: To analyze the current situation of adverse drug reactions (ADRs) monitoring in the tumor patients, and provide evidences for ADR monitoring in the future. Methods: 73 ADR reports collected in 2008 in our hospital were analyzed retrospectively in order to find the characteristics and regularity of ADRs in the tumor patients. Results: Among the 73 ADR cases, 63 cases (accounting for 86.3%) were induced by intravenous injection. 31 Categories of drugs were involved in the ADRs, among which the anticancer drugs ranked the first (45.2%). The main clinical manifestations of ADRs were systemic damages (27.4%) and respiratory system disorders (21.9%), and then followed by the lesions of skin and mucous membrane. Conclusion: ADR monitoring in the tumor patients should be strengthened in order to ensure the safety of drug use. |
| |
Keywords: | Tumor patient Adverse drug reaction Monitoring Rational drug use |
本文献已被 维普 万方数据 等数据库收录! |
|